Deutsche Bank Aktiengesellschaft set a €170.00 ($200.00) price target on Carl Zeiss Meditec (ETR:AFX) in a research report sent to investors on Tuesday morning, Borsen Zeitung reports. The firm currently has a buy rating on the stock.
AFX has been the subject of several other research reports. Nord/LB set a €143.00 ($168.24) price objective on Carl Zeiss Meditec and gave the company a buy rating in a research report on Wednesday, March 3rd. Berenberg Bank set a €127.00 ($149.41) price objective on Carl Zeiss Meditec and gave the company a neutral rating in a research report on Monday, April 19th. DZ Bank reissued a neutral rating on shares of Carl Zeiss Meditec in a research report on Thursday, January 21st. Independent Research set a €97.00 ($114.12) price target on Carl Zeiss Meditec and gave the stock a sell rating in a research report on Tuesday, April 20th. Finally, Kepler Capital Markets set a €145.00 ($170.59) price target on Carl Zeiss Meditec and gave the stock a neutral rating in a research report on Tuesday, April 20th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company. Carl Zeiss Meditec presently has a consensus rating of Hold and a consensus price target of €132.57 ($155.97).
Shares of Carl Zeiss Meditec stock opened at €139.85 ($164.53) on Tuesday. The firm has a market capitalization of $12.51 billion and a PE ratio of 95.98. The firm’s 50 day moving average is €140.15 and its 200 day moving average is €124.67. Carl Zeiss Meditec has a 1 year low of €80.65 ($94.88) and a 1 year high of €151.05 ($177.71). The company has a current ratio of 4.34, a quick ratio of 3.31 and a debt-to-equity ratio of 4.73.
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, France, Spain, India, the United Kingdom, Turkey, North Africa, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Recommended Story: Current Ratio
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.